Hornet Therapeutics is a biotech company focused on developing treatments to address Epstein-Barr Virus (EBV) driven pathologies. The Company was founded by 4BIO Capital and Professor Christoph Hess, based on breakthrough work from Christoph Hess’s lab on translational aspects of lymphocyte function and its metabolic basis. Whilst in incubation, the Company established pioneering single gene-level precision engineering of immune cell metabolism to induce or abolish specific cellular states.
Company Details
- Employees
- 4
- Address
- Epstein-Barr Virus (Ebv) Driven Pathologies. The Company Was Founded By 4bio Capital And Professor Christoph Hess
- Industry
- Biotechnology
- Website
- http://www.hornet-tx.com
Hornet Therapeutics Questions
Hornet Therapeutics's website is http://www.hornet-tx.com
Hornet Therapeutics's LinkedIn profile is https://www.linkedin.com/company/hornet-therapeutics
Hornet Therapeutics has
4 employees.
View email and phone details for 4
employees at Hornet Therapeutics.
Hornet Therapeutics's industry is
Biotechnology
Hornet Therapeutics's top competitors are
March Biosciences,
Micthera,
Enara Bio,
Entact Bio,
Cytospire Therapeutics Ltd,
Trogenix,
Carisma Therapeutics,
Autolus Therapeutics,
Fuse Diagnostics,
Indaco Venture Partners.
Hornet Therapeutics's categories are Biotechnology
